This cruel and unsustainable exploitation of horseshoe crabs is unnecessary. A synthetic alternative to LAL has already been developed and proven to be a reliable replacement for horseshoe crab blood.
NPR has published a powerful exposé about the continued abuse of
horseshoe crabs by the pharmaceutical industry ["Coastal biomedical
labs are bleeding more horseshoe crabs with little accountability].
Every year, hundreds of thousands are taken from shorelines along
the Atlantic coast and partially drained of their unique blue blood,
which contains an enzyme called limulus amebocyte lysate (LAL). This
enzyme helps identify toxic bacteria and has been used for decades
to detect contamination of drugs, vaccines, and medical devices.
Contract research organization Charles River Laboratories reportedly
provides half of the world’s supply of LAL, and profits greatly from
this practice.
The treatment of the horseshoe crabs is shocking: They are either
picked up by the tail (which can cause serious injury) from beaches
where they are mating or are scraped from the bottom of coastal
waters using nets. Hundreds are piled on top of one another in boats
before they are loaded onto trucks and taken to commercial bleeding
facilities. At the lab, their hearts are pierced with catheters to
drain up to half their blood. Many die in the process. In some
states they are then killed and sold as bait, while in others,
including South Carolina and New Jersey, they are returned to the
ocean, despite being weak and in poor health from their enormous
blood loss.
Horseshoe crabs, who have lived on the Earth for over 400 million
years, play an important part in shoreline ecosystems but there is
an alarming correlation between their increased lab use and
decreases in their numbers in the wild. Several shorebird species
rely on the crabs’ eggs as a food source during spring migration,
and the loss of the crabs is endangering their populations as well.
The NPR story noted evidence of indiscriminate harvesting and
violations of permit requirements, as well as a disregard for humane
collection guidelines. Defenders of Wildlife and the South Carolina
Coastal Conservation League have filed a lawsuit against Charles
River and the state of South Carolina for violating the Endangered
Species Act by allowing harvesters to hold captured horseshoe crabs
in manmade ponds.
However, this cruel and unsustainable exploitation of horseshoe
crabs is unnecessary. A synthetic alternative to LAL has already
been developed and proven to be a reliable replacement for horseshoe
crab blood. In 2020, the European Pharmacopoeia Commission announced
its approval of the synthetic equivalent, and pharmaceutical company
Eli Lilly used the alternative to test its COVID-19 antibody
medications and found it to be “cost advantageous” and “better.”
Roche Pharmaceuticals started using the synthetic this year and has
been “able to confirm that it’s fit for its intended use and safe
for patients.”
Unfortunately, the U.S. Pharmacopeia is dragging its feet to approve
the use of the synthetic test, and instead continues to prop up an
industry with a demonstrated disregard for animal welfare and the
environment.